224 related articles for article (PubMed ID: 20523342)
1. IGF2BP2 variations influence repaglinide response and risk of type 2 diabetes in Chinese population.
Huang Q; Yin JY; Dai XP; Pei Q; Dong M; Zhou ZG; Huang X; Yu M; Zhou HH; Liu ZQ
Acta Pharmacol Sin; 2010 Jun; 31(6):709-17. PubMed ID: 20523342
[TBL] [Abstract][Full Text] [Related]
2. Association analysis of SLC30A8 rs13266634 and rs16889462 polymorphisms with type 2 diabetes mellitus and repaglinide response in Chinese patients.
Huang Q; Yin JY; Dai XP; Wu J; Chen X; Deng CS; Yu M; Gong ZC; Zhou HH; Liu ZQ
Eur J Clin Pharmacol; 2010 Dec; 66(12):1207-15. PubMed ID: 20809084
[TBL] [Abstract][Full Text] [Related]
3. The effect of IGF2BP2 gene polymorphisms on pioglitazone response in Chinese type 2 diabetes patients.
Zhang LF; Pei Q; Yang GP; Zhao YC; Mu YF; Huang Q; Zhu YL
Pharmacology; 2014; 94(3-4):115-22. PubMed ID: 25247335
[TBL] [Abstract][Full Text] [Related]
4. Effects of NOS1AP rs12742393 polymorphism on repaglinide response in Chinese patients with type 2 diabetes mellitus.
Wang T; Wang Y; Lv DM; Song JF; Lu Q; Gao X; Zhang F; Guo H; Li W; Yin XX
Pharmacotherapy; 2014 Feb; 34(2):131-9. PubMed ID: 24338736
[TBL] [Abstract][Full Text] [Related]
5. NAMPT -3186C/T polymorphism affects repaglinide response in Chinese patients with Type 2 diabetes mellitus.
Sheng FF; Dai XP; Qu J; Lei GH; Lu HB; Wu J; Xu XJ; Pei Q; Dong M; Liu YZ; Zhou HH; Liu ZQ
Clin Exp Pharmacol Physiol; 2011 Aug; 38(8):550-4. PubMed ID: 21631570
[TBL] [Abstract][Full Text] [Related]
6. NeuroD1 A45T and PAX4 R121W polymorphisms are associated with plasma glucose level of repaglinide monotherapy in Chinese patients with type 2 diabetes.
Gong ZC; Huang Q; Dai XP; Lei GH; Lu HB; Yin JY; Xu XJ; Qu J; Pei Q; Dong M; Zhou BT; Shen J; Zhou G; Zhou HH; Liu ZQ
Br J Clin Pharmacol; 2012 Sep; 74(3):501-9. PubMed ID: 22296034
[TBL] [Abstract][Full Text] [Related]
7. KCNQ1 gene polymorphisms are associated with the therapeutic efficacy of repaglinide in Chinese type 2 diabetic patients.
Dai XP; Huang Q; Yin JY; Guo Y; Gong ZC; Lei MX; Jiang TJ; Zhou HH; Liu ZQ
Clin Exp Pharmacol Physiol; 2012 May; 39(5):462-8. PubMed ID: 22414228
[TBL] [Abstract][Full Text] [Related]
8. Impact of retinol binding protein 4 polymorphism on rosiglitazone response in Chinese type 2 diabetic patients.
Zhou F; Huang Q; Dai X; Yin J; Wu J; Zhou H; Gong Z; Liu Z
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Oct; 36(10):949-57. PubMed ID: 22086013
[TBL] [Abstract][Full Text] [Related]
9. KCNJ11 Lys23Glu and TCF7L2 rs290487(C/T) polymorphisms affect therapeutic efficacy of repaglinide in Chinese patients with type 2 diabetes.
Yu M; Xu XJ; Yin JY; Wu J; Chen X; Gong ZC; Ren HY; Huang Q; Sheng FF; Zhou HH; Liu ZQ
Clin Pharmacol Ther; 2010 Mar; 87(3):330-5. PubMed ID: 20054294
[TBL] [Abstract][Full Text] [Related]
10. A Variation in the ABCC8 Gene Is Associated with Type 2 Diabetes Mellitus and Repaglinide Efficacy in Chinese Type 2 Diabetes Mellitus Patients.
Zhou X; Chen C; Yin D; Zhao F; Bao Z; Zhao Y; Wang X; Li W; Wang T; Jin Y; Lv D; Lu Q; Yin X
Intern Med; 2019 Aug; 58(16):2341-2347. PubMed ID: 31118371
[TBL] [Abstract][Full Text] [Related]
11. A variant of GRK5 is associated with the therapeutic efficacy of repaglinide in Chinese Han patients with type 2 diabetes mellitus.
Shang Z; Han F; Zhou X; Bao Z; Zhu J; Wang T; Lu Q; Du L; Li W; Lv D; Yin X
Drug Dev Res; 2018 May; 79(3):129-135. PubMed ID: 29663513
[TBL] [Abstract][Full Text] [Related]
12. PPARD rs2016520 polymorphism affects repaglinide response in Chinese Han patients with type 2 diabetes mellitus.
Song JF; Wang T; Zhu J; Zhou XY; Lu Q; Guo H; Zhang F; Wang Y; Li W; Wang DD; Cui YW; Lv DM; Yin XX
Clin Exp Pharmacol Physiol; 2015 Jan; 42(1):27-32. PubMed ID: 25311380
[TBL] [Abstract][Full Text] [Related]
13. Impact of genetic polymorphisms of leptin and TNF-alpha on rosiglitazone response in Chinese patients with type 2 diabetes.
Liu HL; Lin YG; Wu J; Sun H; Gong ZC; Hu PC; Yin JY; Zhang W; Wang D; Zhou HH; Liu ZQ
Eur J Clin Pharmacol; 2008 Jul; 64(7):663-71. PubMed ID: 18438653
[TBL] [Abstract][Full Text] [Related]
14. Effect of genetic polymorphism of UCP2-866 G/A on repaglinide response in Chinese patients with type 2 diabetes.
Wang S; Se YM; Liu ZQ; Lei MX; Hao-BoYang ; Sun ZX; Nie SD; Zeng XM; Wu J
Pharmazie; 2012 Jan; 67(1):74-9. PubMed ID: 22393835
[TBL] [Abstract][Full Text] [Related]
15. Association between IGF2BP2 Polymorphisms and Type 2 Diabetes Mellitus: A Case-Control Study and Meta-Analysis.
Rao P; Wang H; Fang H; Gao Q; Zhang J; Song M; Zhou Y; Wang Y; Wang W
Int J Environ Res Public Health; 2016 Jun; 13(6):. PubMed ID: 27294943
[TBL] [Abstract][Full Text] [Related]
16. Serine racemase rs391300 G/A polymorphism influences the therapeutic efficacy of metformin in Chinese patients with diabetes mellitus type 2.
Dong M; Gong ZC; Dai XP; Lei GH; Lu HB; Fan L; Qu J; Zhou HH; Liu ZQ
Clin Exp Pharmacol Physiol; 2011 Dec; 38(12):824-9. PubMed ID: 21933224
[TBL] [Abstract][Full Text] [Related]
17. Association of KCNJ11 and ABCC8 genetic polymorphisms with response to repaglinide in Chinese diabetic patients.
He YY; Zhang R; Shao XY; Hu C; Wang CR; Lu JX; Bao YQ; Jia WP; Xiang KS
Acta Pharmacol Sin; 2008 Aug; 29(8):983-9. PubMed ID: 18664331
[TBL] [Abstract][Full Text] [Related]
18. The association of adiponectin allele 45T/G and -11377C/G polymorphisms with Type 2 diabetes and rosiglitazone response in Chinese patients.
Sun H; Gong ZC; Yin JY; Liu HL; Liu YZ; Guo ZW; Zhou HH; Wu J; Liu ZQ
Br J Clin Pharmacol; 2008 Jun; 65(6):917-26. PubMed ID: 18429970
[TBL] [Abstract][Full Text] [Related]
19. Impact of metformin versus the prandial insulin secretagogue, repaglinide, on fasting and postprandial glucose and lipid responses in non-obese patients with type 2 diabetes.
Lund SS; Tarnow L; Frandsen M; Smidt UM; Pedersen O; Parving HH; Vaag AA
Eur J Endocrinol; 2008 Jan; 158(1):35-46. PubMed ID: 18166815
[TBL] [Abstract][Full Text] [Related]
20. Replication of association study between type 2 diabetes mellitus and IGF2BP2 in Han Chinese population.
Zhang SM; Xiao JZ; Ren Q; Han XY; Tang Y; Yang WY; Ji LN
Chin Med J (Engl); 2013 Nov; 126(21):4013-8. PubMed ID: 24229666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
